GlobalData
GlobalData

Media

The FT, Sky News, Bloomberg, WSJ, along with over 77 other leading press organisations worldwide quote our data and insight and consider us a trusted, independent source.

CRM platforms take center stage with Salesforce leading discussions on Reddit, reveals GlobalData

Customer Relationship Management (CRM) platforms are revolutionizing the way companies engage with their clients by improving communication channels and optimizing business processes, thereby enhancing overall productivity and customer satisfaction. In Q1 2024, Salesforce Inc occupied the first position among the top 5 most mentioned CRM platforms on Reddit, according to the report “Popular CRM Platforms […]
Read more

APAC automotive roof systems market to grow at CAGR of 2.9% over 2023-28, forecasts GlobalData

The demand for luxury vehicles with cutting-edge roof systems is projected to increase due to shifting lifestyle trends and rising disposable income among consumers. It is anticipated that the enforcement of stringent regulations concerning vehicle safety standards and emissions control will also propel the uptake of lightweight and efficient roof systems. Against this backdrop, the […]
Read more

Morgan, Lewis & Bockius and Vinson & Elkins top M&A legal advisers in power sector during Q1 2024, reveals GlobalData

Morgan, Lewis & Bockius and Vinson & Elkins were the top mergers and acquisitions (M&A) legal advisers in the power sector during the first quarter (Q1) of 2024 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database […]
Read more

Goldman Sachs and Lazard top M&A financial advisers in power sector during Q1 2024, reveals GlobalData

Goldman Sachs and Lazard were the top mergers and acquisitions (M&A) financial advisers in the power sector during the first quarter (Q1) of 2024 by value and volume, respectively, according to the latest financial advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database revealed that Goldman Sachs […]
Read more

Biohaven’s Taldefgrobep alfa could target broad SMA patient population, says GlobalData

At the American Academy of Neurology (AAN) 2024 Annual Meeting, Biohaven presented its Phase III RESILIENT (NCT05337553) trial design, which investigates the efficacy and safety of taldefgrobep alfa in patients with spinal muscular atrophy (SMA). Taldefgrobep alfa is a myostatin inhibitor in development as an adjunctive therapy alongside marketed therapies to offer symptomatic relief to […]
Read more

Houlihan Lokey and Lazard top M&A financial advisers in automotive sector during Q1 2024, reveals GlobalData

Houlihan Lokey and Lazard were the top mergers and acquisitions (M&A) financial advisers in the automotive sector during the first quarter (Q1) of 2024 by value and volume, respectively, according to the latest financial advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database reveals that Houlihan Lokey […]
Read more

Oligonucleotides and mRNA vaccines dominate in strategic alliances for RNA-therapies in major APAC countries, says GlobalData

RNA-based therapies have already proven and will continue to play an integral role in the development of novel therapeutic agents for diseases in the future. Against this backdrop, biopharmaceutical companies based in the major Asia-Pacific (APAC) countries (Australia, China, Japan, and South Korea) entered into significant partnerships to develop RNA-based therapies in the last five […]
Read more

With 34% of UK consumers saying they would not use a deposit return scheme, today’s announced delay in rolling out a UK scheme provides more time to address their concerns, says GlobalData

Following the news that the government plans to delay the rollout of a UK-wide deposit return scheme to 2027, Chris Strong, Managing Consultant and Packaging Analyst Consumer Custom Solutions at GlobalData offers his view: “We know that a majority of UK consumers are supportive of a deposit return scheme.  According to GlobalData’s UK consumer survey […]
Read more

APPLAUSE-IgAN trial interim analysis highlights Novartis’ potential to differentiate in IgAN space, says GlobalData

At this year’s World Congress of Nephrology, positive results were presented from Novartis’s pre-specified interim analysis of the Phase III APPLAUSE-IgAN clinical trial. According to the analysis, the use of Fabhalta (iptacopan) was shown to reduce proteinuria in patients with immunoglobulin A (IgA) nephropathy (IgAN) compared to placebo. The drug potentially fills an unmet need […]
Read more
1 141 142 143 144 145 776